{"version":"1.0","type":"link","title":"Real-World Outcomes of Sequential Afatinib and Osimertinib Versus Afatinib and Chemotherapy in EGFR-Mutant NSCLC: Taiwan Multicenter GIANT Study.","author_name":"Ko HW 외","author_url":"https://prs-insight.online/author/Ko%20HW","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/96236","thumbnail_width":1200,"thumbnail_height":630}